Literature DB >> 3882313

Cathepsin B-like cysteine proteinase activity in sputum and bronchoalveolar lavage samples: relationship to inflammatory cells and effects of corticosteroids and antibiotic treatment.

D Burnett, R A Stockley.   

Abstract

Cathepsin B-like activity was measured in lung secretions by using the fluorimetric substrate benzyloxycarbonyl-L-arginine-L-arginine-4-methyl-7-coumarylamide (Z-Arg-Arg-MEC). The enzyme had a pH optimum of approximately 5.5 and had the characteristics of an alkaline-stable cysteine proteinase. Enzyme activity in the sputum from ten subjects with chronic bronchitis was significantly reduced after 5 days' treatment with prednisolone. Seven patients with bronchiectasis were studied before and after 14 days' treatment with amoxycillin. Cysteine proteinase activity was significantly reduced after 7 days' therapy, in parallel with a change in sputum quality from purulent to mucoid. One week after cessation of treatment enzyme levels were again increased but were still significantly lower than pretreatment values. Enzyme activity in 21 bronchoalveolar lavage specimens correlated significantly with neutrophil counts but not with macrophage counts. Cysteine proteinase activity in lung secretions resembles that of cathepsin B but is alkaline-stable, suggesting it is a distinct enzyme. The levels of cysteine proteinase in lung secretions appear to be related to the presence of inflammation or infection.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3882313     DOI: 10.1042/cs0680469

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  9 in total

Review 1.  Factors influencing airway inflammation in chronic obstructive pulmonary disease.

Authors:  A Hill; S Gompertz; R Stockley
Journal:  Thorax       Date:  2000-11       Impact factor: 9.139

Review 2.  alpha-1-Antitrypsin and the pathogenesis of emphysema.

Authors:  R A Stockley
Journal:  Lung       Date:  1987       Impact factor: 2.584

3.  Cartilage proteoglycan aggregate is degraded more extensively by cathepsin L than by cathepsin B.

Authors:  Q Nguyen; J S Mort; P J Roughley
Journal:  Biochem J       Date:  1990-03-01       Impact factor: 3.857

4.  A comparison of four cathepsins (B, L, N and S) with collagenolytic activity from rabbit spleen.

Authors:  R A Maciewicz; D J Etherington
Journal:  Biochem J       Date:  1988-12-01       Impact factor: 3.857

5.  A catalytically active high-Mr form of human cathepsin B from sputum.

Authors:  D J Buttle; B C Bonner; D Burnett; A J Barrett
Journal:  Biochem J       Date:  1988-09-15       Impact factor: 3.857

6.  Elastinolytic activity of human cathepsin L.

Authors:  R W Mason; D A Johnson; A J Barrett; H A Chapman
Journal:  Biochem J       Date:  1986-02-01       Impact factor: 3.857

7.  Immunohistochemical distributions of cathepsin B and basement membrane antigens in human lung adenocarcinoma: association with invasion and metastasis.

Authors:  N Sukoh; S Abe; I Nakajima; S Ogura; H Isobe; K Inoue; Y Kawakami
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

8.  Biochemical quantitation and histochemical localization of cathepsin B, dipeptidyl peptidases I and II, and acid phosphatase in pulmonary granulomatosis and fibrosis in rats.

Authors:  S H Randell; P L Sannes
Journal:  Inflammation       Date:  1988-02       Impact factor: 4.092

9.  Elastase inhibitors of sputum sol phase: variability, relationship to neutrophil elastase inhibition, and effect of corticosteroid treatment.

Authors:  R A Stockley; H M Morrison; J A Kramps; J H Dijkman; D Burnett
Journal:  Thorax       Date:  1986-06       Impact factor: 9.139

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.